Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2238556 | 0.70 | POLB (0.33) | POLB | |
| SCHEMBL1138530 | 0.70 | POLB (0.33) | POLB | |
| SCHEMBL14446948 | 0.67 | — | — | |
| SCHEMBL7040904 | 0.64 | — | — | |
| SCHEMBL9747150 | 0.63 | POLB (0.32) | POLB | |
| SCHEMBL19429338 | 0.60 | KMT2A (0.30) | — | |
| SCHEMBL11406708 | 0.58 | POLB (0.31) | POLB | |
| SCHEMBL5852442 | 0.58 | POLB (0.35) | POLB | |
| SCHEMBL2283493 | 0.56 | POLB (0.30) | POLB | |
| SCHEMBL11514809 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090239907-A1 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | HALOSOURCE, INC. (US) | 2009-09-24 | — | — | US | claimed |
| EP-1996187-A2 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | Halosource, Inc. (US) | 2008-12-03 | — | — | EP | claimed |
| WO-2008115225-A2 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | HALOSOURCE, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| CN-1874959-A | Method and article for maintaining hydantoinylated polymers in a biocidally active state | VANSON HALOSOURCE INC (US) | 2006-12-06 | — | — | CN | claimed |
| JP-3072774-B2 | — | — | 2000-08-07 | — | — | JP | claimed |
| EP-0513239-B1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | UNIV AUBURN (US) | 1998-04-08 | — | — | EP | claimed |
| EP-0513239-A4 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | — | 1993-03-10 | — | — | EP | claimed |
| EP-0513239-A1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | AUBURN UNIVERSITY (US) | 1992-11-19 | — | — | EP | claimed |
| US-5126057-A | Stabilizers against solar radiation | AUBURN RESEARCH FOUNDATION (US) | 1992-06-30 | — | — | US | claimed |
| US-5057612-A | Stable, noncorrosive bicoide, disinfectant | AUBURN RESEARCH FOUNDATION (US) | 1991-10-15 | — | — | US | claimed |
| WO-1991010623-A1 | N,N'-DIHALOIMIDAZOLIDIN-4-ONES | AUBURN UNIVERSITY (US) | 1991-07-25 | — | — | WO | claimed |
| US-8563587-B2 | Methods and compositions for treating fish diseases | HALOSOURCE, INC. (US) | 2013-10-22 | — | — | US | disclosed |
| CN-101863539-A | The glycolylurea fluidized polymer is remained on the method and the article of biocidal activity state | VANSON HALOSOURCE INC | 2010-10-20 | — | — | CN | disclosed |
| US-20090239907-A1 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | HALOSOURCE, INC. (US) | 2009-09-24 | — | — | US | disclosed |
| EP-1996187-A2 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | Halosource, Inc. (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2008115225-A2 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | HALOSOURCE, INC. (US) | 2008-09-25 | — | — | WO | disclosed |
| CN-1874959-A | Method and article for maintaining hydantoinylated polymers in a biocidally active state | VANSON HALOSOURCE INC (US) | 2006-12-06 | — | — | CN | disclosed |
| US-5126057-A | Stabilizers against solar radiation | AUBURN RESEARCH FOUNDATION (US) | 1992-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239907-A1 | METHODS AND COMPOSITIONS FOR TREATING FISH DISEASES | AQP3, AQP1, NISCH | POLB 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.